HealthCor Management’s CATALENT, INC. CTLT Stock Holding History

HealthCor Management’s Portfolio CTLT Stock Details CTLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-270,250	Closed	-$28.1M	–	103
2020 Q4	$28.1M	Buy	+270,250	New	+$26.2M	1.08%	30

Other funds holding CTLT

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HealthCor Management's CTLT Position: Q1 2021 in Review

HealthCor Management sold out of CATALENT, INC. (CTLT) in Q1 2021, closing a stake of 270,250 shares — an estimated $28.1M sold.

HealthCor Management first reported a position in CTLT in Q4 2020 and held it in 1 quarter. The position peaked at $28.1M in Q4 2020. 500 funds tracked by Wall St. Rank hold CTLT as of Q1 2021.

HealthCor Management reported no remaining CATALENT, INC. position as of Q1 2021 after selling out during the quarter.
HealthCor Management sold 270,250 CATALENT, INC. shares in Q1 2021, an estimated $28.1M.
HealthCor Management first reported a position in CATALENT, INC. in Q4 2020 and held it in 1 quarter.
HealthCor Management's CATALENT, INC. position peaked at $28.1M in Q4 2020.
500 funds tracked by Wall St. Rank held CATALENT, INC. as of Q1 2021.

Based on HealthCor Management's 13F filing for Q1 2021, filed 17 May 2021.